These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 16388773)

  • 1. Clinical inquiries. What are effective medication combinations for dyslipidemia?
    Saseen J; Tweed E; Crawford P
    J Fam Pract; 2006 Jan; 55(1):70-2. PubMed ID: 16388773
    [No Abstract]   [Full Text] [Related]  

  • 2. [Coronary disease prevention: only the inhibition of inflammation is important. Why lower lipids, too?].
    Sudhop T; von Bergmann K
    MMW Fortschr Med; 2003 May; 145(21):19. PubMed ID: 12845862
    [No Abstract]   [Full Text] [Related]  

  • 3. Dyslipidaemia in diabetes.
    Patel J
    Clin Evid; 2006 Jun; (15):555-75. PubMed ID: 16973026
    [No Abstract]   [Full Text] [Related]  

  • 4. [Combination pharmacotherapy therapy in the management of atherogenic dyslipidemia].
    Kłosiewicz-Latoszek L; Cybulska B
    Kardiol Pol; 2005 Jun; 62 Suppl 2():II76-80. PubMed ID: 19813341
    [No Abstract]   [Full Text] [Related]  

  • 5. [The best srategies to optimize lipid control: increasing statins dose or ezetimibe coadministration?].
    Polo Romero FJ; Santisteban López Y; Ramírez Relinque L; Rodríguez Martín B
    Rev Clin Esp; 2010 Sep; 210(8):425-6; author reply 426-7. PubMed ID: 20673662
    [No Abstract]   [Full Text] [Related]  

  • 6. Simvastatin + ezetimibe: a combination with no proven advantages.
    Prescrire Int; 2007 Apr; 16(88):67. PubMed ID: 17460829
    [No Abstract]   [Full Text] [Related]  

  • 7. [How can lipid therapy be improved? Cardiologists insist on dual cholesterol inhibition].
    MMW Fortschr Med; 2005 Nov; 147(45):54. PubMed ID: 16320655
    [No Abstract]   [Full Text] [Related]  

  • 8. Rhabdomyolysis associated with the combined use of hydroxymethylglutaryl-coenzyme A reductase inhibitors with gemfibrozil and macrolide antibiotics.
    Landesman KA; Stozek M; Freeman NJ
    Conn Med; 1999 Aug; 63(8):455-7. PubMed ID: 10500341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lowering low-density lipoprotein cholesterol: statins, ezetimibe, bile acid sequestrants, and combinations: comparative efficacy and safety.
    Hou R; Goldberg AC
    Endocrinol Metab Clin North Am; 2009 Mar; 38(1):79-97. PubMed ID: 19217513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [How sure is the combined lipid lowering?].
    Schäfer J
    MMW Fortschr Med; 2005 Jan; 147(1-2):56. PubMed ID: 15704576
    [No Abstract]   [Full Text] [Related]  

  • 11. I have had trouble controlling my cholesterol with a statin alone. Should I consider prescription niacin?
    Johns Hopkins Med Lett Health After 50; 2010 Feb; 21(12):8. PubMed ID: 20344817
    [No Abstract]   [Full Text] [Related]  

  • 12. [Cholesterol goals are now easier to reach. Half LDL cholesterol with only one tablet daily].
    MMW Fortschr Med; 2005 Nov; 147(45):55. PubMed ID: 16320656
    [No Abstract]   [Full Text] [Related]  

  • 13. Drug insight: the role of statins in combination with ezetimibe to lower LDL cholesterol.
    Gotto AM; Farmer JA
    Nat Clin Pract Cardiovasc Med; 2006 Dec; 3(12):664-72. PubMed ID: 17122799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of hyperlipidemia in elderly persons with exercise training, nonpharmacologic therapy, and drug combinations.
    Lavie CJ
    Am J Geriatr Cardiol; 2004; 13(3 Suppl 1):29-33. PubMed ID: 15133427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [When should an association of lipid-lowering drugs be proposed in a patient failing to reach therapeutic targets under monotherapy? Guidelines of the New French Society of Atherosclerosis].
    Farnier M; Bonnet F; Bruckert E; Ferrières J; Paillard F;
    Arch Mal Coeur Vaiss; 2007; 100(6-7):569-81. PubMed ID: 17893640
    [No Abstract]   [Full Text] [Related]  

  • 16. Management of mixed dyslipidemia in patients with or at risk for cardiovascular disease: a role for combination fibrate therapy.
    Fazio S
    Clin Ther; 2008 Feb; 30(2):294-306. PubMed ID: 18343268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. On the road to better dyslipidemia outcomes.
    Hughes S
    Nurse Pract; 2009 Feb; 34(2):14-21; quiz 22. PubMed ID: 19155874
    [No Abstract]   [Full Text] [Related]  

  • 18. [New indications and therapeutic objectives for dyslipidemia].
    Maiques Galán A
    Aten Primaria; 2006 Nov; 38(9):473-5. PubMed ID: 17194348
    [No Abstract]   [Full Text] [Related]  

  • 19. Ezetimibe offers new opportunity to lower LDL-C to target levels.
    Cardiovasc J S Afr; 2005; 16(3):174. PubMed ID: 16049593
    [No Abstract]   [Full Text] [Related]  

  • 20. [Ezetimib--the first selective cholesterol resorption inhibitors. Strengthening of statins].
    MMW Fortschr Med; 2002 Nov; 144(48):52-3. PubMed ID: 12532546
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.